title: Where have all the antibiotic patents gone?
abstract: Patent and regulatory hurdles combined with low returns on investment are stifling antibiotic R&D in the pharmaceutical industry.
authors.affiliation: Wood Phillips, 500 West Madison Street, Suite 3800, Chicago, Illinois 60661-2562, USA. mlkatz@woodphillips.com
authors.forename: Martin L
authors.initials: ML
authors.lastname: Katz
authors.forename: Lisa V
authors.initials: LV
authors.lastname: Mueller
authors.forename: Mark
authors.initials: M
authors.lastname: Polyakov
authors.forename: Steven F
authors.initials: SF
authors.lastname: Weinstock
mesh_terms: D000900:Anti-Bacterial Agents; D017277:Drug Approval / Q000191:economics* / Q000331:legislation & jurisprudence; D015195:Drug Design; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D012106:Research / Q000191:economics* / Q000639:trends
chemical_list: D000900:Anti-Bacterial Agents